KODIFORM THERAPEUTICS LIMITED
Company number 15390647 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£5,000,025
Balance sheet as at 2026-01-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2024-01-05
- Employees
- 4 (2026 accounts)
- Registered office
- Scale Space Building C, 58 Wood Lane, London, England, W12 7RZ
- Postcode
- W12 7RZ
- Capital
- 125 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2026-01-31
- Next due by
- 2027-10-31
- Financial year end
- 31 January
Confirmation statement
- Last statement dated
- 2026-01-04
- Next due by
- 2027-01-18
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 7 current
Thorsten, Dr NOWAK
Director
Malcolm Peter, Dr WEIR
Director
Sally Marianne, Dr DEWHURST
Director
Justian Craig FOX
Director
Benedict STEPHENS
Secretary
Group structure
Controlled by OXFORD SCIENCE ENTERPRISES PLC — since 2024-04-03
From persons-with-significant-control filings on the public register.
Among its peers
Top 25%
by shareholders' funds, of 141 similar companies in W
Trading since 2024.
No.15 of the largest research and experimental development on biotechnology companies in London →
Competitors London
This company ranks 15 among research and experimental development on biotechnology in London.